| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $356.0M | -4.1% |
| Cost of Revenue | $208.7M | +1.5% |
| R&D Expense | $33.1M | -1.9% |
| SG&A Expense | $47.7M | -6.9% |
| Operating Income | -$59.5M | +19.1% |
| Pre-tax Income | -$59.3M | +23.8% |
| Income Tax | $924K | -39.7% |
| Net Income | -$60.2M | +24.1% |
| EPS (Basic) | -$15.53 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.9M | +31.6% |
| Accounts Receivable | $64.3M | +0.7% |
| Current Assets | $108.1M | +10.3% |
| Total Assets | $430.2M | -12.4% |
| Current Liabilities | $131.3M | -28.1% |
| Long-term Debt | $41.2M | — |
| Total Liabilities | $231.0M | -6.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.1M | -37.4% |
| Capital Expenditures | $813K | -48.5% |
| Investing Cash Flow | -$24.1M | -1.2% |
| Financing Cash Flow | $17.6M | +619.2% |
| Free Cash Flow | $17.3M | -36.8% |
| +21.9% |
| EPS (Diluted) | -$15.53 | +21.9% |
| Stockholders' Equity |
| -$8.3M |
| -114.7% |